欧州における双極性障害治療市場の分析

目次

Abstract

This research service provides an assessment of the European bipolar-disorder therapeutics market, maps the key trends and dynamics shaping the industry, provides valuable insights on pipeline analysis and competitive landscape and offers strategic recommendations for the success of the market participants. This study provides an in-depth analysis of the market in terms of the three major classes of drugs used for treatment - atypical antipsychotics, mood stabilisers and anti-depressants - with a specific focus on the key five countries in Europe: Germany, France, the United Kingdom, Italy and Spain.

Table of Contents

1. Executive Summary

• Summary of the European Bipolar-disorder Therapeutics Market
  • Executive Summary

2. Introduction

• Introduction to the European Bipolar-disorder Therapeutics Market
  • Research Scope and Objectives
  • Bipolar-disorder Disease Segmentation
  • Geographic Scope

3. Market Overview

• Overview of the European Bipolar-disorder Therapeutics Market
  • Market Overview

4. Introduction to Bipolar Disorder

• Introduction to Bipolar-disorder Disease
  • Bipolar Disorder- Definition
  • Signs and Symptoms
  • Diagnosis
  • Diagnostic Scales for Bipolar-disorder
  • Risk Factors

5. Management of Bipolar Disorder

• Management of Bipolar Disorder - Drugs Used and Treatment Regimen
  • Classification of Drugs
  • Treatment of Acute Mania
  • Treatment of Depression
  • Treatment of Mixed Episodes and Maintenance Phase
  • Psychological Intervention

6. Epidemiology

• Epidemiology of Bipolar Disorder in Europe
  • Demographics by Country
  • Prevalence of Mood Disorders in Europe
  • Prevalence and Mortality Rates of Bipolar Disorder by Age and Gender
  • Lifetime Prevalence of Co-morbidities with Bipolar Disorder
  • Bipolar-disorder Treatment Statistics in Europe

7. External Challenges: Market Drivers and Restraints for the Total Market

• Industry Challenges, Market Drives and Restraints of the European Bipolar-disorder Therapeutics Market
  • Industry Challenges- Impact and Duration
  • Market Drivers and Restraints
  • Impact Mapping of Drivers and Restraints

8. Market Trends and Revenue Forecasts for the Total Market

• Market Engineering Measurements and Revenue Forecasts
  • Market Engineering Measurements
  • Forecast Assumptions
  • Total Bipolar-disorder Therapeutics Market Revenue Forecast
  • Total Bipolar-disorder Therapeutics Market Revenue Forecast Discussion
  • Bipolar-disorder Therapeutics Market Per Cent of Revenue by Country

9. Competitive Landscape Analysis

• Analysis of the Competitive Landscape of the European Bipolar-disorder Therapeutics Market
  • Competitive Structure
  • Competitive Analysis: Profiling of Selected Key Market Participants
  • Competitive Analysis: Promising Companies in the Future
  • Bipolar-disorder Therapeutics Market Competitive Landscape
  • Analysis of the Marketed Products for Bipolar Disorder
  • Marketed Product Analysis - Bipolar-disorder Medication
  • Marketed Product Analysis - Key Patent Expiries

10. Pipeline Analysis

• Analysis of Potential Bipolar Drug Candidates in Pipeline
  • Late-stage Product Analysis
  • Pipeline Analysis

11. Cost Analysis

• Cost Analysis of the European Bipolar-disorder Therapeutics Market
  • Economic Burden Due to Mood Disorders in Europe
  • Cost Analysis of Mood Disorders
  • Cost Analysis of Bipolar Disorders

12. Regulatory Analysis

• Regulatory Analysis of the European Bipolar-disorder Therapeutics Market
  • The EU Regulatory Framework for Bipolar Disorders
  • Efficacy Criteria
  • Study Population and Design
  • Therapeutic Studies
  • Safety Aspects

13. Atypical Antipsychotic Drugs Segment Breakdown

• Analysis of the Atypical Antipsychotic Drugs Segment for Bipolar Disorder
  • Market Engineering Measurements
  • Atypical Antipsychotic Drugs Segment Revenue Forecast
  • Atypical Antipsychotic Drugs Segment Revenue Forecast Discussion
  • Atypical Antipsychotic Drugs Segment End-user Analysis
  • Atypical Antipsychotic Drugs Segment - A Physician's Perception
  • Atypical Antipsychotic Drugs Segment Competitive Analysis - Market Share
  • Atypical Antipsychotic Drugs Segment Market Share Analysis
  • Atypical Antipsychotic Drugs Segment - Key Marketed Product Analysis

14. Mood-stabilising Drugs

• Analysis of the Mood-stabilising Drugs Segment for Bipolar Disorder
  • Market Engineering Measurements
  • Mood-stabilising Drugs Segment Revenue Forecast
  • Mood-stabilsing Drugs Segment Revenue Forecast Discussion
  • Mood-stabilising Drugs Segment End-user Analysis
  • Mood-stabilising Drugs Segment - A Physician's Perspective
  • Mood-stabilising Drugs Segment Competitive Analysis - Market Share
  • Mood-stabilising Drugs Segment Market Share Analysis
  • Mood-stabilising Drugs Segment - Key Marketed Products Analysis

15. Anti-depressant Drugs Segment Breakdown

• Analysis of the Anti-depressant Drugs Segment for Bipolar Disorder
  • Market Engineering Measurements
  • Anti-depressant Drugs Segment Revenue Forecast
  • Anti-depressant Drugs Segment Revenue Forecast Discussion
  • Anti-depressanr Drugs Segment End-user Analysis
  • Anti-depressant Drugs Segment - A Physician's Perspective
  • Anti-depressant Drugs Segment Competitive Analysis - Market Share
  • Anti-depressant Drugs Segment - Market Share Analysis
  • Anti-depressant Drugs Segment - Key Marketed Products Analysis

16. Germany Breakdown

• Germany Bipolar-disorder Therapeutics Market
  • Germany Market - Market Engineering Measurements
  • Germeny Market Revenue Forecast

17. France Breakdown

• France Bipolar-disorder Therapeutics Market
  • France Market - Market Engineering Measurements
  • France Market Revenue Forecast

18. The United Kingdom Breakdown

• The United Kingdom Biolar-disorder Therapeutics Market
  • The United Kingdom Market - Market Engineering Measurenments
  • The United Kingdom Market Revenue Forecast

19. Italy Breakdown

• Italy Bipolar-disorder Therapeutics Market
  • Italy Market - Market Engineering Measurements
  • Italy Market Revenue Forecast

20. Spain Breakdown

• Spain Bipolar-disorder Therapeutics Market
  • Spain Market - Market Engineering Measurements
  • Spain Market Revenue Forecast

21. The Last Word

• Conclusions and Implications
  • The Last Word - Three Big Predictions

22. Summary of Major Findings

• Summary of Major Findings of the European Bipolar-disorder Therapeutics Market
  • Summary of Major Findings

23. Appendix

• Support Databases
  • Market Engineering Methodology
  • Decision Support Databases
  • List of Abbreviations
  • Database of Key Industry Participants

「欧州における双極性障害治療市場の分析」は2012年05月18日にフロスト・アンド・サリバンより発行されました。 当レポートは税抜￥619,740より販売しています。